Improving the assessment of vancomycin-resistant enterococci by routine screening

Journal of Infectious Diseases

Volumn 195, Issue 3, 2007, Pages 339-346

  Huang, Susan S ^a,b   Rifas Shiman, Sheryl L ^b   Pottinger, Jean M ^c   Herwaldt, Loreen A ^c   Zembower, Teresa B ^d   Noskin, Gary A ^d   Cosgrove, Sara E ^e   Perl, Trish M ^e   Curtis, Amy B ^f,h   Tokars, Jerome L ^f,g   Diekema, Daniel J ^c   Jernigan, John A ^f   Hinrichsen, Virginia L ^b   Yokoe, Deborah S ^a   Platt, Richard ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

^f NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^g CDC   (United States)

^h WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; COHORT ANALYSIS; HIGH RISK POPULATION; INCIDENCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 33846410661     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/510624     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27: 520-32.
2. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003; 51(Suppl 3):13-21.
3. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-85.
4. Centers for Disease Control and Prevention. Campaign to prevent antimicrobial resistance. Available at: http://www.cdc.gov/drugresistance/ healthcare/ha/HASlideSet.ppt. Accessed 7 September 2006.
5. Herrero IA, Issa NC, Patel R. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med 2002; 346: 867-9.
6. Gonzales RD, Schreckenberger PC, Graham MB, Kelkar S, DenBesten K, Quinn JP. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 2001; 357:1179.
7. Bonten MJ, Willems R, Weinstein RA. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1:314-25.
8. Rosenberg J, Jarvis WR, Abbott SL, Vugia DJ, California Emerging Infections Program. Emergence of vancomycin-resistant enterococci in San Francisco Bay area hospitals during 1994 to 1998. Infect Control Hosp Epidemiol 2004; 25:408-12.
9. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001; 344:1427-33.
10. Trick WE, Kuehnert MJ, Quirk SB, et al. Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients. J Infect Dis 1999; 180:391-6.
11. Ostrowsky BE, Venkataraman L, D'Agata EM, Gold HS, DeGirolami PC, Samore MH. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med 1999; 159:1467-72.
12. Warren DK, Kollef MH, Seiler SM, Fridkin SK, Fraser VJ. The epidemiology of vancomycin-resistant Enterococcus colonization in a medical intensive care unit. Infect Control Hosp Epidemiol 2003; 24:257-63.
13. Bonten MJ, Slaughter S, Hayden MK, Nathan C, van Voorhis J, Weinstein RA. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 348:1615-9.
14. Siddiqui AH, Harris AD, Hebden J, Wilson PD, Morris JG Jr, Roghmann MC. The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide. Am J Infect Control 2002; 30:40-3.
15. Cheng AC, Harrington G, Russo P, Liolios L, Spelman D. Rate of nosocomial transmission of vancomycin-resistant enterococci from isolated patients. Intern Med J 2004; 34:510-2.
16. Lai KK, Fontecchio SA, Kelley AL, Baker S, Melvin ZS. The changing epidemiology of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2003; 24:264-8.
17. Montecalvo MA, Jarvis WR, Uman J, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999; 131:269-72.
18. Puzniak LA, Leet T, Mayfield J, Kollef M, Mundy LM. To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2002; 35:18-25.
19. Muller AA, Mauny F, Bertin M, et al. Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis 2003; 36:971-8.
20. Huang SS, Rifas-Shiman SL, Warren DK, et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 2007; 195:330-8 (in this issue).
21. Pelz RK, Lipsett PA, Swoboda SM, et al. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes. Intensive Care Med 2002; 28:692-7.
22. Bach PB, Malak SF, Jurcic J, et al. Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia. Infect Control Hosp Epidemiol 2002; 23:471-4.
23. Zaas AK, Song X, Tucker P, Perl TM. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 2002; 35:1139-46.
24. Price CS, Paule S, Noskin GA, Peterson LR. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 2003; 37:921-8.
25. DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal blood-stream infection. J Infect Dis 2005; 191:588-95.
26. Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant Enterococcus in a level 1 trauma center. Clin Infect Dis 2002; 34:922-9.
27. Baden LR, Thiemke W, Skolnik A, et al. Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance." Clin Infect Dis 2001; 33:1654-60.
28. D'Agata EMC, Gautam S, Green WK, Tang Y-W. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002; 34:167-72.